Standard vs. Biofilm Susceptibility Testing in Cystic Fibrosis (CF)
Status:
Completed
Trial end date:
2007-11-01
Target enrollment:
Participant gender:
Summary
This was a randomized multi-center clinical trial to compare the microbiological efficacy,
clinical efficacy, and safety of using standard versus biofilm susceptibility testing of P.
aeruginosa sputum isolates to guide antibiotic selection for treatment of airway infection in
clinically stable patients with CF.
Phase:
N/A
Details
Lead Sponsor:
Seattle Children's Hospital
Collaborators:
Cystic Fibrosis Foundation Cystic Fibrosis Foundation Therapeutics